Glioblastoma multiforme: an overview of emerging therapeutic targets

OG Taylor, JS Brzozowski, KA Skelding - Frontiers in oncology, 2019 - frontiersin.org
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain
tumour in humans and has a very poor prognosis. The existing treatments have had limited …

Glioblastoma: current status, emerging targets, and recent advances

A Thakur, C Faujdar, R Sharma, S Sharma… - Journal of Medicinal …, 2022 - ACS Publications
Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous
population of genetically unstable and highly infiltrative cells that are resistant to …

[HTML][HTML] Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells

ML Suvà, E Rheinbay, SM Gillespie, AP Patel… - Cell, 2014 - cell.com
Developmental fate decisions are dictated by master transcription factors (TFs) that interact
with cis-regulatory elements to direct transcriptional programs. Certain malignant tumors …

Eph receptors and ephrins in cancer progression

EB Pasquale - Nature Reviews Cancer, 2024 - nature.com
Evidence implicating Eph receptor tyrosine kinases and their ephrin ligands (that together
make up the 'Eph system') in cancer development and progression has been accumulating …

Cancer stem cells in glioblastoma

JD Lathia, SC Mack, EE Mulkearns-Hubert… - Genes & …, 2015 - genesdev.cshlp.org
Tissues with defined cellular hierarchies in development and homeostasis give rise to
tumors with cellular hierarchies, suggesting that tumors recapitulate specific tissues and …

Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells

H Tadokoro, T Umezu, K Ohyashiki, T Hirano… - Journal of Biological …, 2013 - ASBMB
Hypoxia plays an important role during the evolution of cancer cells and their
microenvironment. Emerging evidence suggests communication between cancer cells and …

Therapeutic targeting of EPH receptors and their ligands

AW Boyd, PF Bartlett, M Lackmann - Nature reviews Drug discovery, 2014 - nature.com
Critical roles for EPH receptor (EPH)–ephrin signalling in a range of chronic and
regenerative diseases are increasingly being recognized. In particular, the complex roles of …

A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma

BW Stringer, BW Day, RCJ D'Souza, PR Jamieson… - Scientific reports, 2019 - nature.com
Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard
for preclinical studies and cellular investigations of glioblastoma (GBM) biology, yet …

Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases

Q Huang, Y Chen, W Zhang, X Xia, H Li, M Qin… - Journal of Controlled …, 2024 - Elsevier
Despite the increasing global incidence of brain disorders, achieving sufficient delivery
towards the central nervous system (CNS) remains a formidable challenge in terms of …

Eph receptors and ephrins: therapeutic opportunities

A Barquilla, EB Pasquale - Annual review of pharmacology and …, 2015 - annualreviews.org
The e rythropoietin-p roducing h epatocellular carcinoma (Eph) receptor tyrosine kinase
family plays important roles in developmental processes, adult tissue homeostasis, and …